WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 8101 Infant (under 12 months) mortality rate: 562
GDP / capita (US$): 1'7031 Child (under 5 years) mortality rate: 762

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 10'317  10'174  10'033  9'896  9'765  8'578  7'110  5'692 
Births 265  265  265  265  265  267  265  239 
Surviving infants 254  254  254  254  253  250  241  209 
Pop. less than 5 years 1'250  1'250  1'247  1'241  1'237  1'224  1'161  914 
Pop. less than 15 years 3'607  3'598  3'588  3'578  3'567  3'459  3'068  2'339 
Female 15-49 years 2'719  2'671  2'623  2'577  2'531  2'102  1'643  1'369 

Number of reported case

(Click for retrospective incidence data for Haiti)
Diphtheria 16  23 
Japanese encephalitis
Measles 992  1'414  507 
Mumps
Pertussis 14  913  812 
Polio* 20 
Rubella
Rubella (CRS)
Tetanus (neonatal) 15  40  143 
Tetanus (total) 15  143  381 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Haiti)
Vaccine year result method % card seen                                                
BCG 2011  83  DHS   73  75  74  82  64  66  57  72  26 
DTP1 2011  88  DHS   73  90  99  95  75  73 
DTP3 2011  63  DHS   73  85  85  85  67  68  59  41 
HepB_BD         
HepB3          85 
Hib3          85 
JapEnc         
MCV 2011  65  DHS   73  80  69  58  45  60  80  31 
MCV2         
PCV1         
PCV3         
Pol3 2011  59  DHS   73  92  80  79  62  65  58  40 
Rota1         
Rota_last         
Rubella1          80  66  45  17 
TT2plus 2011  65  DHS   73  57  59  61  43  16 
PAB         
VAD1          99*  100  36  91  52 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Haiti)
BCG 83  83  83  82  80  72  72 
DTP1 86  86  86  85  84  73  66  21 
DTP3 68  68  68  67  65  49  41 
HepB3 68 
HepB_BD
Hib3 68 
MCV 65  65  65  64  63  55  31 
MCV2
PAB 76  76  70  70  70  41  39  14 
PCV3
Pol3 67  67  67  66  65  50  40 
Rota_last

Number of districts in the country 140  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
86 
   
/
|
|
\
Greater or equal to 90% 43
From 80 to 89% 14
From 50 to 79% 24
Less than 50% 19
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwP 6, 10, 14 weeks; Yes
DTwPHibHep 6, 10, 14 weeks; Yes
MR 9 months; Yes
OPV birth; 6, 10, 14 weeks; Yes
Pneumo_conj Yes From April 2015
Pneumo_ps Yes From January 2015
Rotavirus Yes From April 2014
Td 1st contact; +4 weeks; +6 months; +1, +1 years; Yes pregnant women
VitaminA 6,12 months; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes    Yes  Yes  Yes 
What years does the MYP cover? number 2011-2015  2011-2015  2011-2015    2009-2013  2009-2013  2004-2008 
Nº of districts with microplans that include activities to raise immunization coverage number 105    36    140  133  133 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR   No  Yes         

System performance

Total Nº districts in country number 140  144  141  133  140  133  133 
Nº districts with DTP3 coverage >=80% number 80  68  70  91  62  38  12 
% of districts with DTP3 coverage >=80% From 0 to 100% 57  47  50  68  44  29 
Nº districts with measles (MCV1) coverage >=95% number 49  26  21  61   
% of districts with MCV1 coverage >=95% From 0 to 100% 35  18  15  46   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  No  No         
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  No  No    Yes    No 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100%    

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.